Xtant Medical Inc.
XTNT | AMEX
$0.48
-$0.02 (-4.84%)
At close: May 13, 2026, 3:59 PM ET
-4.84%
(1D)Rating
Updated: May 9, 2026Key Statistics
Market Data
Market Cap $67.27M
1D Range
0.47 0.52
52W Range
0.44 0.95
Valuation (TTM)
PE 14.33
PB 1.32
EV/EBITDA 4.97
Valuation (NTM)
Forward PE 145.75
Forward PEG N/A
Price Target $1.50
Cash Flow
FCF Yield 15.1%
SBC Adj. FCF Yield 11.8%
SBC Impact -22.1%
Margins
Gross Margin 62.9%
Operating Margin 5.4%
FCF Margin 7.6%
Growth (CAGR)
Revenue 3Y | 5Y 32.2% |
20.2%
Dil EPS 3Y | 5Y 44.4% |
22.4%
FCF 3Y | 5Y 81.0% |
109.3%
Returns
ROA 5.3%
ROE 10.3%
ROIC 6.5%
Financial Health
Net Debt
$8.33M
Current Ratio 2.65
Interest Coverage 1.98
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. I...
Sector Healthcare
Industry Medical - Devices
Employees 217
IPO Date Jun 30, 2010
Website www.xtantmedical.com
Fiscal Year n/a
Latest News
No news articles available yet.
Earnings
Latest Earnings
May 13, 2026
EPS
-$0.02
Miss -66.67%
YoY:
-5100.00% REV
$20.88M
Beat +3.57%
YoY:
-36.53%Add to Watchlist
Select watchlists to add or remove XTNT